Comparing Acutus Medical (NASDAQ:AFIB) and Spectral Medical (OTCMKTS:EDTXF)

Acutus Medical (NASDAQ:AFIB) and Spectral Medical (OTCMKTS:EDTXF) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

Earnings and Valuation

This table compares Acutus Medical and Spectral Medical”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acutus Medical	$7.16 million	0.45	-$81.66 million	N/A	N/A
Spectral Medical	$1.18 million	112.27	-$11.60 million	($0.05)	-9.45

Spectral Medical has lower revenue, but higher earnings than Acutus Medical.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Acutus Medical and Spectral Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acutus Medical	0	0	0	0	N/A
Spectral Medical	0	0	0	0	N/A

Profitability

This table compares Acutus Medical and Spectral Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Acutus Medical	N/A	-105.86%	-10.79%
Spectral Medical	-967.95%	N/A	-252.38%

Institutional & Insider Ownership

56.9% of Acutus Medical shares are held by institutional investors. 5.2% of Acutus Medical shares are held by company insiders. Comparatively, 1.5% of Spectral Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Acutus Medical beats Spectral Medical on 5 of the 8 factors compared between the two stocks.

About Acutus Medical

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

About Spectral Medical

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.